Response of conventional chondrosarcoma to gemcitabine alone: a case report

We report on an 18-month-long tumour response to gemcitabine as single agent in a young patient with an advanced secondary peripheral conventional chondrosarcoma, previously treated unsuccessfully with anthracyclines, ifosfamide, platinum, etoposide.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research